HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

Louis: muscle loss on GLP-1 drugs reflects calorie restriction catabolism

Louis Nervegna · Jun 09, 2025 · ♥ 6 reactions · 18 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)Weight, visceral & liver fat
AI summary & key facts

Louis offers a personal explanation that muscle loss on GLP-1 agonists is part of how calorie restriction works, with brief catabolic periods and autophagy clearing damaged tissue. He argues the standard diet keeps people anabolic nearly all the time. No studies are cited.

In case you’re wondering why people lose muscle mass on GLP-1 agonists.

This is how calorie restriction is supposed to work. Brief periods of catabolism are not a bad thing.

We need catabolic processes like autophagy to clear out damaged tissue and stimulate repair.

The standard American diet and lifestyle puts us in anabolism nearly 100% of the time. This is not a good thing.

#calorierestriction#muscle#autophagy
← newer: MESA calculator converts a CAC score into a 10-year heart atolder: CAC score above 300 carries a 10-year prognosis similar to a →